New study aims to sharpen dengue diagnosis
NCT ID NCT07203183
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will collect blood samples from 200 people aged 12 and older who either have or do not have dengue. The goal is to use these samples to develop and improve diagnostic tests for dengue. Participants must have symptoms consistent with dengue and cannot have been vaccinated for the disease or be in other clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate and faster dengue diagnostic tests.
- What could go wrong
- This is a sample collection study, not a treatment trial. It does not test any new therapy or vaccine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists deliberately infect volunteers with dengue to unlock immune secrets
- Could papaya leaves help fight dengue? new trial tests the idea
- Dengue danger linked to leaky gut? new study investigates
- Exercise program aims to restore strength after dengue and chikungunya
- New dengue drug trial aims to shorten illness and lower virus levels
- Can existing COVID drug beat dengue? new trial begins